← Back to Search

Retail Environments for Tobacco Smoking

N/A

Waitlist Available

Led By Emily Falk, PhD

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between the ages of 21-65

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at how smoking affects the brain and behavior, as well as exposure to smoking in specific environments.

Who is the study for?

This study is for English-speaking smokers aged 21-65 who smoke at least 5 cigarettes daily for the past 6 months. Participants must own a smartphone, be fully vaccinated against COVID-19, and reside in PA, DE, NJ or the Philadelphia area for the next 3 months with limited absences.

What is being tested?

The trial aims to understand how smokers' brains and behaviors are influenced by their everyday environments, particularly retail spaces like convenience stores (7-11) and pharmacies (CVS).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

This trial's timeline: 3 weeks for screening, Varies for treatment, and for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Brain activity (measured by functional magnetic resonance imaging), in a priori regions of interest, in response to smoking vs nonsmoking cues (all 822815 participants and fMRI subset of 850796 participants)

Neural cue reactivity region definition (822815 participants and fMRI subset of 850796 participants)

Self-reported cigarette craving during the experimental manipulation period

+1 more